Zhitong Finance App News, Minovar (603538.SH) issued an announcement. Recently, Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. (“Menova Tiankang” for short), a wholly-owned subsidiary of the company, participated in the 12th batch of centralized national drug procurement work organized by the State Organization Drug Joint Procurement Office. Alogliptin oral regular release dosage forms are to be selected for this centralized procurement.

In October 2024, Menohuatiankang received the “Drug Registration Certificate” for agliptin benzoate tablets approved and issued by the State Drug Administration. As of the end of June 2026, the company's products had not been sold in the domestic market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.